Evidence map›Paper›PMID 24569990›Full record

ArticleThe Journal of biological chemistry2014

Inhibiting tyrosine phosphorylation of protein kinase Cδ (PKCδ) protects the salivary gland from radiation damage.

Sten M Wie, Tariq S Adwan, James DeGregori, Steven M Anderson, Mary E Reyland

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Mechanisms of radiation-induced endothelium damage: Emerging models and technologies.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2021
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sten M WieProgram in Structural Biology and Biochemistry; Department of Craniofacial Biology, School of Dental Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045.
Tariq S AdwanDepartment of Craniofacial Biology, School of Dental Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045.
James DeGregoriDepartment of Biochemistry and Molecular Genetics, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045.
Steven M AndersonDepartment of Pathology, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045.
Mary E ReylandDepartment of Craniofacial Biology, School of Dental Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado 80045. Electronic address: mary.reyland@ucdenver.edu.
University of Colorado Anschutz Medical Campus · US

Funding

University of Colorado Cancer Center Support Grant - Lung Cancer Patient-Derived Xenografts with Autologous Human Immune SystemsP30CA046934 · NCI · UNIVERSITY OF COLORADO DENVER · PI James V Degregori · 1988 to 2026
$117.0M
Regulation of Salivary Cell Apoptosis by Protein Kinase CR01DE015648 · NIDCR · UNIVERSITY OF COLORADO DENVER · PI REYLAND, MARY ELAINE · 2004 to 2019
$5.6M
Aging-associated alterations in adaptive landscapes and the evolution of leukemiaR01CA180175 · NCI · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V · 2013 to 2018
$1.8M
Rationally designed targeted therapeutic approaches for NSCLCR01CA157850 · NCI · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V · 2011 to 2015
$1.5M
Is GLUT1 required for tumor growth and the Warburg Effect?R01CA138482 · NCI · UNIVERSITY OF COLORADO DENVER · PI ANDERSON, STEVEN M · 2011 to 2013
$535k
Nrf2-mediated impaired hematopoietic stem cell fitness following irradiationR21CA179501 · NCI · UNIVERSITY OF COLORADO DENVER · PI DEGREGORI, JAMES V · 2015 to 2016
$372k
NCI NIH HHS 1R01CA180175NCI NIH HHS P30 CA046934NCI NIH HHS P30CA046934NCI NIH HHS R01 CA138482NCI NIH HHS R01CA138482NCI NIH HHS R01 CA157850NCI NIH HHS R01 CA180175NCI NIH HHS R21 CA179501NIDCR NIH HHS 5R01DE015648NIDCR NIH HHS R01 DE015648
6 · The paper itself

Abstract

Radiation therapy for head and neck cancer can result in extensive damage to normal adjacent tissues such as the salivary gland and oral mucosa. We have shown previously that tyrosine phosphorylation at Tyr-64 and Tyr-155 activates PKCδ in response to apoptotic stimuli by facilitating its nuclear import. Here we have identified the tyrosine kinases that mediate activation of PKCδ in apoptotic cells and have explored the use of tyrosine kinase inhibitors for suppression of irradiation-induced apoptosis. We identify the damage-inducible kinase, c-Abl, as the PKCδ Tyr-155 kinase and c-Src as the Tyr-64 kinase. Depletion of c-Abl or c-Src with shRNA decreased irradiation- and etoposide-induced apoptosis, suggesting that inhibitors of these kinases may be useful therapeutically. Pretreatment with dasatinib, a broad spectrum tyrosine kinase inhibitor, blocked phosphorylation of PKCδ at both Tyr-64 and Tyr-155. Expression of "gate-keeper" mutants of c-Abl or c-Src that are active in the presence of dasatinib restored phosphorylation of PKCδ at Tyr-155 and Tyr-64, respectively. Imatinib, a c-Abl-selective inhibitor, also specifically blocked PKCδ Tyr-155 phosphorylation. Dasatinib and imatinib both blocked binding of PKCδ to importin-α and nuclear import, demonstrating that tyrosine kinase inhibitors can inhibit nuclear accumulation of PKCδ. Likewise, pretreatment with dasatinib also suppressed etoposide and radiation induced apoptosis in vitro. In vivo, pre-treatment of mice with dasatinib blocked radiation-induced apoptosis in the salivary gland by >60%. These data suggest that tyrosine kinase inhibitors may be useful prophylactically for protection of nontumor tissues in patients undergoing radiotherapy of the head and neck.

Indexed as

Active Transport, Cell Nucleusalpha KaryopherinsAnimalsApoptosisCell NucleusCSK Tyrosine-Protein KinaseDasatinibDNA DamageFemaleHEK293 CellsHumansMiceMice, Inbred C57BLMicroscopy, FluorescencePhosphorylationProtein Bindingalpha KaryopherinsCSK protein, humanCSK Tyrosine-Protein KinaseDasatinibProtein Kinase C-deltaProto-Oncogene Proteins c-ablPyrimidinessrc-Family KinasesThiazolesTyrosineApoptosisNonreceptor Tyrosine KinaseProtein Kinase C (PKC)Radiation BiologySalivary Gland

Identifiers

PMID24569990
PMCPMC4036201
OpenAlexW2013675913

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.